Cannapharmarx Stock Fundamentals
| CPMD Stock | USD 0.01 0.00 0.00% |
CannaPharmaRx fundamentals help investors to digest information that contributes to CannaPharmaRx's financial success or failures. It also enables traders to predict the movement of CannaPharmaRx Pink Sheet. The fundamental analysis module provides a way to measure CannaPharmaRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CannaPharmaRx pink sheet.
CannaPharmaRx |
CannaPharmaRx Company Shares Outstanding Analysis
CannaPharmaRx's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current CannaPharmaRx Shares Outstanding | 257.57 M |
Most of CannaPharmaRx's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CannaPharmaRx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, CannaPharmaRx has 257.57 M of shares currently outstending. This is 42.67% higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 54.96% higher than that of the company.
CannaPharmaRx Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CannaPharmaRx's current stock value. Our valuation model uses many indicators to compare CannaPharmaRx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CannaPharmaRx competition to find correlations between indicators driving CannaPharmaRx's intrinsic value. More Info.CannaPharmaRx is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CannaPharmaRx's earnings, one of the primary drivers of an investment's value.CannaPharmaRx Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CannaPharmaRx's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CannaPharmaRx could also be used in its relative valuation, which is a method of valuing CannaPharmaRx by comparing valuation metrics of similar companies.CannaPharmaRx is currently under evaluation in shares outstanding category among its peers.
CannaPharmaRx Fundamentals
| Return On Equity | -2.51 | |||
| Return On Asset | -0.26 | |||
| Current Valuation | 20.13 M | |||
| Shares Outstanding | 257.57 M | |||
| Shares Owned By Insiders | 1.12 % | |||
| Price To Book | 11.05 X | |||
| EBITDA | (6.07 M) | |||
| Net Income | (8.83 M) | |||
| Cash And Equivalents | 5.18 K | |||
| Total Debt | 14.96 M | |||
| Debt To Equity | 7.05 % | |||
| Book Value Per Share | (0.07) X | |||
| Cash Flow From Operations | (2.41 M) | |||
| Earnings Per Share | (0.12) X | |||
| Beta | 0.21 | |||
| Market Capitalization | 2.83 M | |||
| Total Asset | 114.33 K | |||
| Retained Earnings | (28.64 M) | |||
| Working Capital | (285 K) | |||
| Current Asset | 233 K | |||
| Current Liabilities | 518 K | |||
| Net Asset | 114.33 K |
About CannaPharmaRx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CannaPharmaRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CannaPharmaRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CannaPharmaRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.CannaPharmaRX, Inc. operates in the cannabis industry in Canada. The company was incorporated in 1998 and is based in Calgary, Canada. Cannapharmarx operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in CannaPharmaRx Pink Sheet
CannaPharmaRx financial ratios help investors to determine whether CannaPharmaRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CannaPharmaRx with respect to the benefits of owning CannaPharmaRx security.